This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
The SVR rate is 40%, not 50%.
Rash as a side effect is not a deal killer, not if "suicidal ideation" can make it past the FDA when they approved IFN. There is also a rash from riba, quite severe for some folks and riba made it past the FDA.
with numbers like 500,000 of us trying to clear or non-responding, Telapravir is on the lips of my doctor as being approved in 2 years. The stock price can go to hell and come back between now and then, but ole Doc Scott is involved in the HALT-C trial, a Gilead trial and consults for a Vertex trial starting in Washington, so I believe the man.
I was nice to the writer of the article, but I had many disagreements with what he was writing. How much value is there in being able to bring an UND in four weeks, by itself? Even to a slow moving organization like the FDA? And then let the SOC take over for 24 weeks? Very much value, I think, just on that one aspect of Telapravir. And to shorten time from 48 to 24 weeks of SOC? More value, I believe. Even if SVR rates didn't change one whit, to rewrite protocols to include Telapravir and only 24 weeks has much value, saves money and shortens our exposure to IFN and the damage it does. Telapravir and it's rash....for me, the rash is would be welcome over what I still experience from IFN.
It's all so interesting, stock price is irrelevant now tho in my mind. The bigger picture, for those of us non-responders, Telapravir may add a great twist to the story.
Have a good one.
Ranting, wondering WIllow
They really suffered and it required stopping meds for some. In addition the rash affects three times as many people taking VX as rashes affect those on SOC. Some had to be administered heavy doses of steroids just to try to control it. Rashes of this type that are confluent can be extremely dangerous. Our skin is our largest organ and the situation is a big concern. I was hospitalized once for a confluent rash and told it could kill me, so I know how serious they can be. As I recall from participants reports it took quite some time for it to resolve completely. That will trouble the FDA Im afraid. Im still optimistic that they can resolve the issue.
The fact that they approved SOC with "suicidal ideation" affecting a tiny percentage is no different than many many other drugs that have that listed in their warnings where everything and the kitchen sink is listed to avoid liability. Most all psychotropic drugs have this warning as well as sleep aids and Im sure many other types of drugs too. This is due I would think more to the fact that a large portion of the population suffers from depression and a fraction of those will have suicidal ideation regardless of what meds they are taking.
In my view there is no way the drugs will be available in "two years" to everyone. The trials coming up don't even start until summer and then it will be weill into next year before they are even done.
I too have watched the market closely lately and think it might be time to buy more Vertex, not sell off. I don't think shareholders know any more than the rest of us, hungering for a better treatment.
The author did make some good points in watching the numbers they use to analyze their data.
frijole
As for the "suicidal ideation", part of the protocol for Hep C and it's diagnosis and tx has listed for docs is to check for depression and start anti-dees if they deem necessary. Or deny the patient treatment if they are too depressed. I don't mean to sound flippant, but to write off the depression aspects of IFN as "a large percentage of the population is depressed" does not answer the issue of the FDA approving many drugs, in spite of terrible side effects.
We are not doctors, Kalio, I have never claimed to be. All I can relay is what Doc Scott from the University of Washingtons liver and hep clinic wrote me in our last weekly correspondence. And he wrote, chided me actually and said that "the drug will be approved in the next two years." He was telling me to chill and wanting me to back down from pressing him to treat me again with SOC. But with my daughter being in med school there and in contact with Doc Scott, he knows that I get good info, so if he fibs to me, I know it.
Actually, this will be amazing, but I trust him and his expertise. Trust is almost as wonderful as hope.
Willow
If it makes tx more tolorable and increases the odds of slaying the dragon for many more than current tx regimen does, then it's great! But it still seems to fall far short of being a silver bullet. Is it really the blessing many seem to think it is if newer drugs like VX950 bring yet another round of sx's which makes tx impossible or more burdensome?
Be "wery wery" careful what you wish for! ;-)
But thankfully you survived it and you are probably right now clear of this creepy virus! Even though the rash is discoraging for everyone waiting on it's approval, I am so encouraged by the fact that it looks like most reporting back are SVR. Even if it doesn't make it to market, at least you guys were cured!!
I hope you are hanging in there and things are going ok.
Let's just pray there is a bit of hope on the horizon, wrapped in a rash or not. Telapravir is not a silver bullet, but then, we ain't huntin werewolves. Personally, as a non-responder, I am learning to embrace the word "combo". Then all my suffering can be at one time. I get tired of it all now.
Willow speaking rashly?
-- Jim
willows - I know where you're coming from and I don't blame you. I'd want access to it too, even if it did come with a significant chance of a rash. I'd take my chances with it, just like I did rather blindly when signing up for this trial in the first place. Bottomline is that the closer our livers move towards cirrhosis, the more the luxury of time slips away. When that situation arises, our hands are forced into making tough decisions based on limited/imperfect information and living with their associated risks and lack of guarantees. Bottomline is that I'm guessing telaprevir will make it to the market - with significant side effects, but with a significant improvement in odds of treatment success too. Lets keep our fingers crossed.
jim - Your rashes do sound awful, and I know you're still struggling with it. Hoping you're coming along aok.
Over the years, I observed so many promising drugs... but for one reason or another they did not reach of the FDA approval.
I hope this one will be approved and be suitable for some patients.
Willow
Speak for yourself, Sister!!
My guess is that there's a lot of pent up demand that may or may not be factored in to current share price. I get the sense that a lot of GI's are advising patients with moderate damage to wait for a better mousetrap. And VX could be that trap.
Hoping that all works out.
I have watched all of the conferences and at one they said that they think the rash may be due to the combination of the ribaviron with the VX. Maybe if the arms that have no riba work out and the sides will not be that bad for just VX & interferon.
I really respect all of you that are willing to be the guinea pigs for this drug.
Thank you for writing the author of this article, though I haven't read it.
Mremeet, I hear the same ticking clock that you do.
Hopefully people will see this part of my post. Does anyone here get scared or nervous about posting their concerns, problems or fears re treatment due to the fact that Vertex or doctors may be reading our posts? I hope I'm not becoming paranoid. I have things I'd like to say/share that now I'm worried about saying/sharing since I read recent posts about Vertex reading our comments and have seen some of our threads showing up on internet news sites. I wish there was a more secure way for us to talk about these things.
Chris - Vertex is watching this site, make no mistake about it. I don't know what it is you wish to discuss, but I'd be willing to speak with you in private if it would help. If you're interested leave your email address and I'll drop you a line.
Im so glad you were able to avoid the rash, I was astonished that some of the participants who visit here managed to keep going, what an incredible sign of their tenacity that is! You guys are all such trail blazers for everyone of us. I hope even if it does get bogged down with issues that require them to go back to the drawing board all of the participants will succeed in clearing the virus and acheive SVR. You all deserve it, that's for sure.
------------------------------------
I don't want you to think I was trying to minimize the effect the rash had on some in the Vertex group. The point was that, yes, many of us would take our chances with the rash in return for a shortened 12-24 week treatment verus what some of us went though in 48 weeks or more of treatment. While I may not be able to walk in your rash, you also aren't able to walk in my 54 weeks of one problem after another after another. Some people think being eaten by ants is better than eaten by a bear but I'm not so sure. Glad btw that some of those tips worked out!
-- Jim